Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

SODIUM FLUORIDE F 18

SODIUM FLUORIDE F-18

Standard Dose
10-200mCi/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview SODIUM FLUORIDE F 18 is listed in Drugs@FDA under application 022494 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient SODIUM FLUORIDE F-18 Form and strength INJECTABLE;INTRAVENOUS - 10-200mCi/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor NIH NCI DCTD Submission history Latest submission status date: 2011-01-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview SODIUM FLUORIDE F 18 is listed in Drugs@FDA under application 022494 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient SODIUM FLUORIDE F-18 Form and strength INJECTABLE;INTRAVENOUS - 10-200mCi/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor NIH NCI DCTD Submission history Latest submission status date: 2011-01-26 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.
SODIUM FLUORIDE F 18 (SODIUM FLUORIDE F-18) | Drug Monograph | MedicHelpline